The Montreal Health Innovations Coordinating Center   Report issue

For profit Phase 2 Phase 3
Founded: Montreal Canada (1954)
Status: No NME R&D (1954)

Organization Overview

First Clinical Trial
2015
NCT02387229
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Montreal Heart Institute 5000 Belanger Street, Montreal, PQ Canada H1T1C8 | The Montreal Health Innovations Coordinating Center (MHICC)